arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

SkinHealth Systems Inc.

SKIN

$10.32 ▼ -0.95 (-8.43%) at close

8 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

SkinHealth Systems Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3B

Dividend Yield —

Revenue Growth -10.0% ↗

Op. Margin -6.9% ↗

ROIC -54.6% ↗

FCF / Share $0.29 ↗

Trailing P/E —

Price / Book 21.6x

FCF Yield 2.9%

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$300.79M

↓ -10.0% —

Net Income Profit after all expenses

$-9.52M

↑ +67.3% —

Operating Margin Operating profit as % of sales

-6.9%

↑ +65.9% 18th

FCF / Share Free cash flow per share

$0.29

↑ +136.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-10.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-225%)	-16.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-300%)	8.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10%)	40.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+408%)	118.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1380%)	-28.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-457%)	—	—
EPS Growth YoY (%)	65.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	69.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-331.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-1600.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	67.3% Excellent Excellent Year-over-year change in net income	70.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	-1185.7% Weak Weak Year-over-year change in net income	-1681.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	136.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-8.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	N/M	-105.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	16.6% Good Good Year-over-year change in free cash flow	-112.0% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-6.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.7% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	49.5% Excellent Excellent Compound annual revenue growth over 3 years	30.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	20.4% Excellent Excellent Compound annual revenue growth over 5 years	14.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-6.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-146%)	-20.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-235%)	-32.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-319%)	-7.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-147%)	-14.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-194%)	-14.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-196%)	8.1% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-46%)	—
Effective Tax Rate (%) (%)	-60.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.2% Fair Fair Actual taxes paid relative to pre-tax income Optimal: 15-25%	44.2% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-3.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-126%)	-8.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-173%)	-25.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-310%)	12.1% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-144.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1302%)	-24.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	-1.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-108%)	—
FCF Margin (%) (%)	12.4% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-32.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-15.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-13.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-4.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-3.91x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.53x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.18x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	4.30x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-54.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-128.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-216.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	43.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-621.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-4.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-15.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-56.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-474%)	-168.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1224%)	26.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+76%)	-124.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-927%)	97.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+549%)	135.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+804%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	-1.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.59x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.93x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	0.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	$-523.02M	$-568.20M	$-901.89M	$-9.49M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$2.38	$2.70	$3.02	$2.48	$2.55	$3.47	$5.18	—
Basic EPS, GAAP (USD)	$-0.08	$-0.23	$-0.76	$0.30	$-3.67	$-0.85	$-0.05	—
Free Cash Flow per Share (USD)	$0.29	$0.12	$0.14	$-0.80	$-0.39	$-0.46	$-0.22	—
Book Value per Share (USD)	$0.48	$0.41	$0.48	$1.26	$2.01	$-0.84	$-0.04	—
Tangible Book Value per Share (USD)	$-0.51	$-0.57	$-0.54	$0.32	$1.19	$-3.62	$-3.10	—
Basic Weighted Avg Shares (shares)	126.38M	123.83M	131.68M	147.55M	102.11M	34.29M	32.14M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$123.24M	$408.97M	$583.24M	$711.56M	$924.46M	$28.16M	—	—
Total Equity (USD)	$61.06M	$51.80M	$59.39M	$167.05M	$302.30M	$-29.96M	$-1.21M	$294.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$300.79M	$334.29M	$397.99M	$365.88M	$260.09M	$119.09M	$166.62M	—
Depreciation Expense (USD)	$3.85M	$9.94M	$11.33M	$7.16M	$4.49M	$2.55M	$1.38M	—
Net Income, GAAP (USD)	$-9.52M	$-29.10M	$-100.12M	$44.22M	$-375.11M	$-29.18M	$-1.64M	—
Operating Cash Flow (USD)	$37.48M	$16.13M	$21.75M	$-106.60M	$-28.36M	$-12.44M	$1.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 28 quarters

SkinHealth Systems Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SKIN with peers